NASDAQ Composite opens in less than two hours and Inovio Pharmaceuticals‘s pre-market value is already 6.67% up.

The last session, NASDAQ Composite finished with Inovio Pharmaceuticals jumping 1.26% to $8.84. NASDAQ Composite slid 0.99% to $13,857.84, following last session’s downward trend on what was a somewhat rough trend exchanging session.

Inovio Pharmaceuticals’s last close was $8.24, 282.24% under its 52-week high of $33.79.

Inovio Pharmaceuticals’s Sales

Inovio Pharmaceuticals’s sales growth is a negative 35.2% for the current quarter and 233.3% for the next. The company’s growth estimates for the current quarter and the next is 30.8% and 77.1%, respectively.

Inovio Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 1896.7%, now sitting on 7.41M for the twelve trailing months.

Inovio Pharmaceuticals’s Stock Yearly Top and Bottom Value

Inovio Pharmaceuticals’s stock is valued at $8.84 at 08:11 EST, way under its 52-week high of $33.79 and way higher than its 52-week low of $6.88.

Inovio Pharmaceuticals’s Moving Average

Inovio Pharmaceuticals’s worth is way under its 50-day moving average of $10.61 and way under its 200-day moving average of $11.28.


Inovio Pharmaceuticals’s last day, last week, and last month’s current volatility was 5.83%, 2.09%, and 2.56%, respectively.

Inovio Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 8.31% (day), 4.46% (last week), and 5.49% (last month), respectively.

More news about Inovio Pharmaceuticals.


Please enter your comment!
Please enter your name here